Levetiracetam may worsen myoclonus in patients with juvenile myoclonic epilepsy: Case reports

Clinical Neuropharmacology

Volumn 35, Issue 4, 2012, Pages 201-202

  Babtain, Fawzi A ^a  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

juvenile myoclonus epilepsy; levetiracetam; myoclonus; paradoxical response

Indexed keywords

ETIRACETAM; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DRUG DOSE ESCALATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MYOCLONUS EPILEPSY; PREGNANCY; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; ANTICONVULSANTS; FEMALE; HUMANS; MYOCLONIC EPILEPSY, JUVENILE; MYOCLONUS; PIRACETAM; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863944843     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31825eed8c     Document Type: Article

References (12)

1. Kaminski RM, Matagne A, Leclercq K, et al. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 2008;54(4):715-720.
2. Boon P, Chauvel P, Pohlmann-Eden B, et al. Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy. Epilepsy Res 2002;48(1-2):77-89. (Pubitemid 34127719)
3. Glauser TA, Ayala R, Elterman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006;66(11):1654-1660. (Pubitemid 43964617)
4. Brodie MJ, Perucca E, Ryvlin P, et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007;68(6):402-408. (Pubitemid 46208740)
5. Noachtar S, Andermann E, Meyvisch P, et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008;70(8):607-616. (Pubitemid 351294638)
6. Berkovic SF, Knowlton RC, Leroy RF, et al. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007;69(18):1751- 1760. (Pubitemid 350059304)
7. Grunewald R, Panayiotopoulos CP. Juvenile myoclonic epilepsy: a review. Arch Neurol 1993;50:594-598. (Pubitemid 23165587)
8. Harden CL, Hopp J, Ting TY, et al. Practice parameter update: management issues for women with epilepsyVfocus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73(2):126-132.
9. Mantoan L, Walker M. Treatment options in juvenile myoclonic epilepsy. Curr Treat Options Neurol 2011;13(4):355-370.
10. Afra P, Adamolekun B. Lacosamidetreatment of juvenile myoclonic epilepsy. Seizure 2012;21(3):202-204.
11. Sazgar M, Bourgeois BF. Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol 2005;33(4):227-234. (Pubitemid 41382499)
12. Fattore C, Boniver C, Capovilla G, et al. A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. Epilepsia 2011;52(4):802-809.